WorldQuant Millennium Advisors
RPRX icon

WorldQuant Millennium Advisors’s Royalty Pharma RPRX Stock Holding History

WorldQuant Millennium Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,251
Closed -$1.6M – 567
2025
Q1 		$1.6M Sell
51,251
-558,922
-92% -$17.7M 0.01% 359
2024
Q4 		$15.6M Buy
610,173
+201,648
+49% +$5.35M 0.1% 211
2024
Q3 		$11.6M Sell
408,525
-8,933
-2% -$247K 0.08% 218
2024
Q2 		$11M Buy
417,458
+218,496
+110% +$6.06M 0.1% 208
2024
Q1 		$6.04M Sell
198,962
-35,685
-15% -$1.05M 0.07% 229
2023
Q4 		$6.59M Sell
234,647
-342,257
-59% -$9.41M 0.09% 207
2023
Q3 		$15.7M Sell
576,904
-43,362
-7% -$1.29M 0.24% 125
2023
Q2 		$19.1M Buy
620,266
+361,108
+139% +$12.2M 0.32% 102
2023
Q1 		$9.34M Buy
+259,158
New +$9.61M 0.17% 168
2022
Q1 		– Sell
-14,094
Closed -$562K – 353
2021
Q4 		$562K Sell
14,094
-140,898
-91% -$5.47M 0.01% 289
2021
Q3 		$5.6M Buy
154,992
+39,763
+35% +$1.55M 0.12% 201
2021
Q2 		$4.72M Buy
+115,229
New +$4.9M 0.1% 205

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $2.93B AUM 37.21% 1-Year Est. Return

WorldQuant Millennium Advisors's RPRX Position: Q2 2025 in Review

WorldQuant Millennium Advisors sold out of Royalty Pharma (RPRX) in Q2 2025, closing a stake of 51,251 shares — an estimated $1.6M sold.

WorldQuant Millennium Advisors first reported a position in RPRX in Q2 2021 and held it in 12 quarters. The position peaked at $19.1M in Q2 2023. 454 funds tracked by Wall St. Rank hold RPRX as of Q2 2025.

  • WorldQuant Millennium Advisors reported no remaining Royalty Pharma position as of Q2 2025 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 51,251 Royalty Pharma shares in Q2 2025, an estimated $1.6M.
  • WorldQuant Millennium Advisors first reported a position in Royalty Pharma in Q2 2021 and held it in 12 quarters.
  • WorldQuant Millennium Advisors's Royalty Pharma position peaked at $19.1M in Q2 2023.
  • 454 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2025.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.